Growth Metrics

Cabaletta Bio (CABA) Change in Account Payables (2018 - 2025)

Cabaletta Bio's quarterly Change in Account Payables came in at -$1.7 million in Q4 2025, down 163.12% year-on-year from $2.7 million in Q4 2024, and down 259.44% quarter-over-quarter from $1.1 million in Q3 2025.

Cabaletta Bio has reported Change in Account Payables for 8 years, with the latest figure at -$1.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Change in Account Payables fell 163.12% year-over-year to -$1.7 million; the trailing twelve-month figure through Dec 2025 stood at $1.5 million (up 53.31% YoY), and the FY2025 full-year result was $1.5 million, up 53.31% from the prior year.
  • Change in Account Payables for Q4 2025 stood at -$1.7 million, down from $1.1 million in the prior quarter.
  • The five-year high for Change in Account Payables was $2.7 million in Q4 2024, with the low at -$2.0 million in Q3 2024.
  • Average Change in Account Payables over 5 years is $259150.0, with a median of $580500.0 recorded in 2021.
  • Peak annual rise in Change in Account Payables reached 620.36% in 2022, while the deepest fall reached 304.07% in 2022.
  • Tracing CABA's Change in Account Payables over 5 years: stood at $566000.0 in 2021, then jumped by 81.45% to $1.0 million in 2022, then tumbled by 49.56% to $518000.0 in 2023, then surged by 421.81% to $2.7 million in 2024, then slumped by 163.12% to -$1.7 million in 2025.
  • The last three Change in Account Payables figures came in at -$1.7 million (Q4 2025), $1.1 million (Q3 2025), and $595000.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Account Payables (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -3.26 Mn
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 35.60 Mn
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Cabaletta Bio 194.84 Mn 61.24 Mn - -1.71 Mn

Historic Data

Download Data 🔒
DateValue
Dec 31, 2025 -1.71 Mn
Dec 31, 2025 -1.71 Mn
Sep 30, 2025 1.07 Mn
Sep 30, 2025 1.07 Mn
Jun 30, 2025 595,000.00
Jun 30, 2025 595,000.00
Mar 31, 2025 1.59 Mn
Mar 31, 2025 1.59 Mn
Dec 31, 2024 2.70 Mn
Dec 31, 2024 2.70 Mn
Sep 30, 2024 -2.01 Mn
Sep 30, 2024 -2.01 Mn
Jun 30, 2024 -1.34 Mn
Jun 30, 2024 -1.34 Mn
Mar 31, 2024 1.66 Mn
Mar 31, 2024 1.66 Mn
Dec 31, 2023 518,000.00
Dec 31, 2023 518,000.00
Sep 30, 2023 1.30 Mn
Sep 30, 2023 1.30 Mn
Jun 30, 2023 -1.87 Mn
Jun 30, 2023 -1.87 Mn
Mar 31, 2023 1.72 Mn
Mar 31, 2023 1.72 Mn
Dec 31, 2022 1.03 Mn
Dec 31, 2022 1.03 Mn
Sep 30, 2022 -893,000.00
Sep 30, 2022 -893,000.00
Jun 30, 2022 -1.87 Mn
Jun 30, 2022 -1.87 Mn
Mar 31, 2022 1.71 Mn
Mar 31, 2022 1.71 Mn
Dec 31, 2021 566,000.00
Dec 31, 2021 566,000.00
Sep 30, 2021 -221,000.00
Sep 30, 2021 -221,000.00
Jun 30, 2021 959,000.00
Jun 30, 2021 959,000.00
Mar 31, 2021 -329,000.00
Mar 31, 2021 -329,000.00
Dec 31, 2020 496,000.00
Dec 31, 2020 496,000.00
Sep 30, 2020 -139,000.00
Sep 30, 2020 -139,000.00
Jun 30, 2020 -978,000.00
Jun 30, 2020 -978,000.00
Mar 31, 2020 1.18 Mn
Mar 31, 2020 1.18 Mn
Dec 31, 2019 -306,000.00
Dec 31, 2019 -306,000.00
Sep 30, 2019 672,000.00
Sep 30, 2019 672,000.00
Jun 30, 2019 182,000.00
Jun 30, 2019 182,000.00
Mar 31, 2019 -302,000.00
Mar 31, 2019 -302,000.00
Dec 31, 2018 374,000.00
Dec 31, 2018 374,000.00